Reserpine administration (5 mg/kg, i.p.) to guinea pigs resulted in marked and long lasting dopamine (DA) depletion and a rapid, short lasting, increase of 3,4-dihydroxyphenylacetic acid (DOPAC) in the striatum. A marked and sustained increase of the level of 5-S-cysteinyl-dopamine, which is an adduct presumably formed following autoxidation of DA, started 3–4 h following the DA and DOPAC changes. Only small changes in the levels of the 5-S-cysteinyl adducts of DOPAC and 3,4-dihydroxyphenylalanine (DOPA) were found.
This is a preview of subscription content, log in via an institution to check access.
Access this article Subscribe and saveSpringer+ Basic
€34.99 /Month
Price includes VAT (Germany)
Instant access to the full article PDF.
Similar content being viewed by others Explore related subjectsDiscover the latest articles and news from researchers in related subjects, suggested using machine learning. ReferencesAgrup G, Edholm L-E, Rorsman H, Rosengren E (1983) Diastereomers of 5-S-cysteinyl-DOPA. Acta Derm Venereol (Stockh) 63: 59–61
Ambani LM, Melvin H, Van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32: 114–118
Anton AH, Sayre DF (1962) A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360–375
Carlsson A (1965) Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Erspamer V (ed) 5-Hydroxytryptamine and related indolealkylamines. Springer, Berlin Heidelberg New York, pp 529–592 [Born GVR et al (eds) Handbook of experimental pharmacology, vol 19]
Carlsson A, Lindqvist M (1978) Effect of reserpine on monoamine synthesis and on apparent dopaminergic receptor sensitivity in rat brain. In: Haber B, Aprison MH (eds) Neuropharmacol behavior. Plenum, New York, pp 89–102
Cohen G (1983) The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence. J Neural Transm 19 [Suppl]: 89–103
Fornstedt B, Rosengren E, Carlsson A (1986) Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 25: 451–454
Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C 1300 Neuroblastoma cells in vitro. Mol Pharmacol 14: 644–653
Milliken GA, Johnson DE (1984) Analyses of messy data. Lifetime Learning Publications, Belmont, CA
Moldéus P, Nordenskjöld M, Bolcsfoldi G, Eiche A, Haglund U, Lambert B (1983) Genetic toxicity of dopamine. Mutation Res 124: 9–24
Rosengren E, Linder-Eliasson E, Carlsson A (1985) Detection of 5-S-cysteinyldopamine in human brain. J Neural Transm 63: 247–253
Scheulen M, Wollenberg P, Bolt HM, Kappus H, Remmer H (1975) Irreversible binding of dopa and dopamine metabolites to protein by rat liver microsomes. Biochem Biophys Res Comm 66: 1396–1400
Wick MM (1978) Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol 71: 163–164
Wick MM, Byers L, Frei E III (1979) L-Dopa: selective toxicity for melanoma cells in vitro. Science 197: 468–469
Wick MM (1980) Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res 40: 1414–1418
B. Fornstedt
Present address: Department of Pharmacology, University of Göteborg, Göteborg, Sweden
Department of Pharmacology, University of Göteborg, Göteborg, Sweden
A. Carlsson
Fornstedt, B., Carlsson, A. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. J. Neural Transmission 76, 155–161 (1989). https://doi.org/10.1007/BF01578755
Received: 12 January 1989
Accepted: 13 January 1989
Issue Date: June 1989
DOI: https://doi.org/10.1007/BF01578755
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4